N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells-Reference-Cited by-同舟云学术

N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells

Published:2016-08-02 Issue:sup3 Volume:31 Page:140-149
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Prestegui-Martel Berenice¹,Bermúdez-Lugo Jorge Antonio¹,Chávez-Blanco Alma²,Dueñas-González Alfonso³,García-Sánchez José Rubén⁴,Pérez-González Oscar Alberto⁵,Padilla-Martínez Itzia Irene⁶,Fragoso-Vázquez Manuel Jonathan¹,Mendieta-Wejebe Jessica Elena¹,Correa-Basurto Ana María¹,Méndez-Luna David¹,Trujillo-Ferrara José¹,Correa-Basurto José¹

Affiliation:

1. Laboratorio de Modelado Molecular y Bioinformática, Laboratorio de Bioquímica, Laboratorio de Biofísica y Biocatálisis, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Ciudad de México, México,

2. División de Investigación Básica, Instituto Nacional de Cancerología, Tlalpan, Sección XVI, Ciudad de México, México,

3. Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México/Instituto Nacional de Cancerología, Ciudad de México, México,

4. Laboratorio de Oncología Molecular y Estrés Oxidativo, Sección de Estudios de Posgrado e Investigación, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón, Ciudad de México, México,

5. Laboratorio de Oncología Experimental, Instituto Nacional de Pediatría, Coyoacán, Insurgentes Cuicuilco, Ciudad de México, México, and

6. Unidad Profesional Interdisciplinaria de Biotecnología, Instituto Politécnico Nacional, Barrio La Laguna Ticomán, Ciudad de México, México

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2016.1210138

Reference47 articles.

1. The context and potential of epigenetics in oncology

2. Improvements in survival from childhood cancer: results of a population based survey over 30 years

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dendrimers as drug delivery systems for oncotherapy: Current status of promising applications;International Journal of Pharmaceutics;2024-09

2. The Importance of Structural Water in HDAC8 for Correct Binding Pose Applied for Drug Design of Anticancer Molecules;Anti-Cancer Agents in Medicinal Chemistry;2024-09

3. N-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression;Molecules;2024-07-26

4. Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines;International Journal of Molecular Sciences;2023-09-26

5. Hepatotoxic Evaluation of N-(2-Hydroxyphenyl)-2-Propylpentanamide: A Novel Derivative of Valproic Acid for the Treatment of Cancer;Molecules;2023-08-28